Voyager Therapeutics
在场
高管
查看带有其 18 名主要高管的组织结构图
Voyager Therapeutics 搜索最多的简介
- Alfred Sandrock, Chief Executive Officer and Director
- Michael Higgins, Chairman of the Board
- Steven Hyman, Director
高管在Voyager Therapeutics变化
- Toby FergusonToby Ferguson 将于20243月25作为 Chief Medical Officer 加入公司 (新闻发布的2024三月14号).
- Beth Shafer已作为Chief Business Officer加入公司 (新闻发布的2023八月8号).
创建提醒
跟踪 Voyager Therapeutics 的高管变动
生物技术
Voyager Therapeutics 拥有 2,279 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Adaptive Phage Therapeutics (美国(美洲))。
Popular M&A news in 生物技术
- Metsera 刚刚宣布为 290 筹款数百万美元。 (公布2024四月23号).
- Histogen has filed for bankruptcy protection (公布2024四月19号).
- Bruker has announced the acquisition of NanoString Technologies (公布2024四月18号).
生物技术 行业的其他推荐联系人
消息
Voyager Therapeutics 的最新新闻稿
- Voyager Therapeutics Reports Third Quarter 2023 Financial and Operating Results | Voyager Therapeutics Inc.
- Voyager Therapeutics Announces Third Quarter 2023 Conference Call and Webcast | Voyager Therapeutics Inc.
- Voyager Therapeutics to Present at the Chardan Genetic Medicines Conference | Voyager Therapeutics Inc.
- Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Voyager Therapeutics Inc.
- Voyager Therapeutics to Participate in Upcoming Investor Conferences | Voyager Therapeutics Inc.
- Voyager Therapeutics Presents New Data Demonstrating Novel Candidate Therapeutic Antibodies Reduced Tau Pathology in Multiple Preclinical Models | Voyager Therapeutics Inc.
- Voyager Therapeutics to Present Second Quarter 2022 Results and Corporate Update | Voyager Therapeutics Inc.
- Voyager Therapeutics Appoints Catherine J. Mackey, Ph.D. to its Board of Directors | Voyager Therapeutics Inc.
- Voyager Therapeutics’ TRACER™ Capsids Demonstrate Enhanced CNS Transduction Across Species; New Preclinical Results Bolster GBA1, Tau, SOD1 ALS Gene Therapy Programs | Voyager Therapeutics Inc.
- Voyager Therapeutics to Present Preclinical Data from its Vectorized anti-HER2 Antibody Program and a Novel AAV5-Derived TRACER™ Capsid at the 25th American Society of Gene and Cell Therapy Annual Meeting | Voyager Therapeutics Inc.
- View more press releases Close
通过电子邮件
